Newspaper advertisement published for Q2 and H1 FY27 results

Compliance View source PDF Explain this filing

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+6.8%Reaction day

₹1229.50

prior close

₹1260.00

announcement price

After-mkt

timing

Nifty 100market+0.7%+6.1% vs market

Pharmaceuticals peers, median of 174sector+1.2%+5.6% vs sector

On the reaction day the stock moved 6.1 pts more than Nifty 100 and 5.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.2

10m

+0.8

15m

+0.3

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+6.8+0.7+6.1+1.2+5.6

Next day

+6.5+1.0+5.6+3.1+3.4

+8.6pendingpending+4.7+3.9

—————

15d

—————

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Reddy's published in Business Standard and Andhra Prabha on Oct. 24 an advertisement covering its unaudited standalone and consolidated results for the quarter and half-year ended Sept. 30, 2026. The board approved the results on Oct. 23. The ad reports revenue and profit growth, margin improvement and FY27 guidance, with quarterly capital expenditure of about Rs 720 crore.

Likely market impact

The filing is neutral because it only republishes approved results; any stock reaction will follow the reported growth, margins and FY27 guidance.